PMC:7600245 / 41571-42003
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T156 | 141-149 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T157 | 380-388 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T380 | 23-31 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T381 | 205-213 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T312 | 0-432 | Sentence | denotes | One is to evaluate the activity, safety and reduction in mortality of two regimens of low-dose selinexor in patients with moderate or severe COVID-19 (NCT04355676, n = 80) and the other is to evaluate the activity of low-dose selinexor and its effect on the clinical recovery, viral load, length of hospitalization, and rate of morbidity and mortality in participants with severe COVID-19 compared to placebo (NCT04349098, n = 230). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1251 | 108-116 | Species | denotes | patients | Tax:9606 |
| 1252 | 355-367 | Species | denotes | participants | Tax:9606 |
| 1253 | 95-104 | Chemical | denotes | selinexor | MESH:C585161 |
| 1254 | 226-235 | Chemical | denotes | selinexor | MESH:C585161 |
| 1256 | 57-66 | Disease | denotes | mortality | MESH:D003643 |
| 1257 | 141-149 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1258 | 342-351 | Disease | denotes | mortality | MESH:D003643 |
| 1259 | 380-388 | Disease | denotes | COVID-19 | MESH:C000657245 |